target="_blank" rel="nofollow" href="http://dx.doi.org/10.1016/j.vaccine.2003.12.006">[CrossRef]
Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. 1995. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333:1732–1736.[PubMed][CrossRef]
Henderson DK. 2006. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Am J Med 119(Suppl 1):S45–S52, discussion S62–S70.[PubMed][CrossRef]
Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG II, Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA, The Vaginal Infections and Prematurity Study Group. 1995. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 333:1737–1742.[PubMed][CrossRef]
Hooper J. 1999. A new germ theory. Atl Mon 283:41–53. [An excellent example of H. pylori fever at work. The scientists interviewed in the article believe that virtually all “big old diseases are infectious.”]
Keeling MJ, Rohani P. 2007. Modeling Infectious Diseases in Humans and Animals. Princeton University Press, Princeton, NJ.
Landro L. 5 April 2006. Hospitals get aggressive about hand washing. Wall Street Journal, New York, NY. http://www.wsj.com/articles/SB114418621366316925.
Macías AE, Ponce-de-León S. 2005. Infection control: old problems and new challenges. Arch Med Res 36:637–645.[PubMed][CrossRef]
Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, Reynolds L, Kenyon C, Giambrone G, Kudish K, Miller L, Selvage D, Lee A, Skoff TH, Kamiya H, Cassiday PK, Tondella ML, Clark TA. 2015. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 60:223–227.[PubMed][CrossRef]
Mirmonsef P, Spear GT. 2014. The barrier to HIV transmission provided by genital tract Lactobacillus colonization. Am J Reprod Immunol 71:531–536.[PubMed][CrossRef]
Morens DM, Fauci AS. 2013. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog 9:e1003467.[PubMed][CrossRef]
Neely MN, Pfeifer JD, Caparon M. 2002. Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun 70:3904–3914.[PubMed][CrossRef]
Pennsylvania Health Care Cost Containment Council. 2005. Hospital-acquired infections. http://www.phc4.org/reports/cabg/04/keyfindings.htm.
Thomson JM, Bonomo RA. 2005. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! Curr Opin Microbiol 8:518–524.[PubMed][CrossRef]
Van Beneden CA, Keene WE, Strang RA, Werker DH, King AS, Mahon B, Hedberg K, Bell A, Kelly MT, Balan VK, Mac Kenzie WR, Fleming D. 1999. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 281:158–162.[PubMed][CrossRef]
Van Winkelhoff AJ, Boutaga K. 2005. Transmission of periodontal bacteria and models of infection. J Clin Periodontol 32(Suppl 6):16–27.[PubMed][CrossRef]
Waterfield NR, Wren BW, Ffrench-Constant RH. 2004. Invertebrates as a source of emerging human pathogens. Nat Rev Microbiol 2:833–841.[PubMed][CrossRef]
Wheeler A, Smith HS. 2013. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology 306:124–146.[PubMed][CrossRef]
Wilson BA. 2008. Global biosecurity in a complex, dynamic world. Complexity 14:71–88.[CrossRef]
Woolhouse MEJ, Webster JP, Domingo E, Charlesworth B, Levin BR. 2002. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet 32:569–577.[PubMed][CrossRef]
World Health Organization. 2014. Antimicrobial resistance: Global report on surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/.
Questions
1. The number of human deaths is often used as a standard for ranking human diseases in terms of importance. What, if anything, is wrong with this classification scheme?
2. Infectious diseases have obvious deleterious effects on the infected individual. Are there other consequences that reach beyond the infected person to his or her family and to society as a whole?
3. The United States and most developed countries have long had medical communities that focus on therapy rather than prevention. Why is this the case and under what conditions might this emphasis be appropriate? Why are scientists arguing for a return to a prevention-based health care system?
4. In our classification of emerging or reemerging infectious diseases, we treated antibiotic-resistant bacteria and E. coli O157:H7 as new diseases. Make the case for and against considering a member of an established disease-causing species that acquires a new trait as a new disease entity. What is the